ATE378038T1 - Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege - Google Patents

Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege

Info

Publication number
ATE378038T1
ATE378038T1 AT04743268T AT04743268T ATE378038T1 AT E378038 T1 ATE378038 T1 AT E378038T1 AT 04743268 T AT04743268 T AT 04743268T AT 04743268 T AT04743268 T AT 04743268T AT E378038 T1 ATE378038 T1 AT E378038T1
Authority
AT
Austria
Prior art keywords
microemulsions
respiratory diseases
preventing respiratory
particles
polar lipid
Prior art date
Application number
AT04743268T
Other languages
English (en)
Inventor
Per Wollmer
Morgan Andersson
Lennart Greiff
Thomas Landh
Original Assignee
Nares Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0302005A external-priority patent/SE0302005D0/xx
Priority claimed from SE0302006A external-priority patent/SE0302006D0/xx
Application filed by Nares Ab filed Critical Nares Ab
Application granted granted Critical
Publication of ATE378038T1 publication Critical patent/ATE378038T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04743268T 2003-07-07 2004-07-07 Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege ATE378038T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48466403P 2003-07-07 2003-07-07
SE0302005A SE0302005D0 (sv) 2003-07-07 2003-07-07 New composition
SE0302006A SE0302006D0 (sv) 2003-07-07 2003-07-07 New Microemulsions

Publications (1)

Publication Number Publication Date
ATE378038T1 true ATE378038T1 (de) 2007-11-15

Family

ID=34068955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04743268T ATE378038T1 (de) 2003-07-07 2004-07-07 Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege

Country Status (7)

Country Link
EP (1) EP1648412B1 (de)
JP (2) JP5037939B2 (de)
AT (1) ATE378038T1 (de)
DE (1) DE602004010130T2 (de)
ES (1) ES2297442T3 (de)
PL (1) PL1648412T3 (de)
WO (1) WO2005004843A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2618974C (en) 2005-08-09 2014-01-28 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity
WO2007060177A1 (en) 2005-11-22 2007-05-31 Nestec S.A. Oil-in-water emulsion and its use for the delivery of functionality
JP4686763B2 (ja) * 2006-01-31 2011-05-25 独立行政法人産業技術総合研究所 針一体型バイオセンサー
EP2349209A2 (de) * 2008-09-26 2011-08-03 Nanobio Corporation Therapeutische zusammensetzungen in nanoemulsionsform und anwendungsverfahren dafür
WO2014197398A1 (en) * 2013-06-03 2014-12-11 Tolmar, Inc. Corticosteroid compositions
KR101743142B1 (ko) 2015-09-09 2017-06-02 강원대학교산학협력단 즉시 사용가능한 마이크로에멀젼 기반의 비강내 면역화용 면역보강제 조성물
CN110200915A (zh) * 2019-05-14 2019-09-06 扬子江药业集团江苏紫龙药业有限公司 一种富马酸卢帕他定乳剂型鼻腔喷雾剂及其制备方法
JP7505930B2 (ja) * 2020-06-29 2024-06-25 小林製薬株式会社 濃縮鼻腔粘膜洗浄用組成物
WO2022030607A1 (ja) * 2020-08-06 2022-02-10 Ｎｅｘｔ Ｉｎｎｏｖａｔｉｏｎ合同会社 病原微生物のミセル化除去手段
IT202000024484A1 (it) * 2020-10-16 2022-04-16 Synapticom S R L Soluzione liposomiale con capacita’ di interagire con il particolato atmosferico, nelle cavita' nasali riducendo la velocita' di assorbimento delle particelle inspirate

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
JP3324264B2 (ja) * 1994-03-23 2002-09-17 大正製薬株式会社 鼻洗浄剤
GB9409778D0 (en) * 1994-05-16 1994-07-06 Dumex Ltd As Compositions
WO1995031956A1 (en) * 1994-05-20 1995-11-30 Novavax, Inc. Antibacterial oil-in-water emulsions
US5653987A (en) * 1995-05-16 1997-08-05 Modi; Pankaj Liquid formulations for proteinic pharmaceuticals
WO1999007341A1 (en) * 1997-08-09 1999-02-18 Smithkline Beecham Plc Compositions for nasal administration
US6015832A (en) * 1997-12-31 2000-01-18 The Regents Of The University Of Michigan Methods of inactivating bacteria including bacterial spores
JP2000109425A (ja) * 1998-10-02 2000-04-18 Lion Corp 花粉破裂防止剤、花粉破裂防止方法及び粘膜用洗浄剤
US6635676B2 (en) * 1999-04-28 2003-10-21 Regents Of The University Of Michigan Non-toxic antimicrobial compositions and methods of use
US6506803B1 (en) * 1999-04-28 2003-01-14 Regents Of The University Of Michigan Methods of preventing and treating microbial infections
US6296882B1 (en) * 2000-06-12 2001-10-02 Manuel Viamonte, Jr. Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil
AUPQ875700A0 (en) * 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions

Also Published As

Publication number Publication date
DE602004010130D1 (de) 2007-12-27
JP5037939B2 (ja) 2012-10-03
PL1648412T3 (pl) 2008-04-30
JP2012051892A (ja) 2012-03-15
ES2297442T3 (es) 2008-05-01
EP1648412A1 (de) 2006-04-26
JP2007526885A (ja) 2007-09-20
EP1648412B1 (de) 2007-11-14
WO2005004843A1 (en) 2005-01-20
JP5604395B2 (ja) 2014-10-08
DE602004010130T2 (de) 2008-09-18

Similar Documents

Publication Publication Date Title
EP4360651A3 (de) Glp-1-zusammensetzungen und verwendungen davon
WO2006031606A3 (en) Carboxamide spirolactam cgrp receptor antagonists
EP1797073A4 (de) Bicyclische anilidspirolactame als antagonisten des cgrp-rezeptors
DE60133323D1 (de) Cardioprotektive Phosphonate
NO20062767L (no) Immunoglobuliner
NO20090596L (no) Antivirale fosfinatforbindelser
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
DE602004013563D1 (de) Rantagonisten
ATE506951T1 (de) Als inhibitoren von beta-secretase aktive tertiäre carbinamine mit substituierten heterocyclen zur behandlung der alzheimer- krankheit
NO20092470L (no) Substituerte diazepanforbindelser som orexinreseptorantagonister
ATE275836T1 (de) Produkt und methode zur reduzierung der stress induzierten immununterdrückung
SE0301010D0 (sv) Novel compounds
ATE361067T1 (de) Naphtoquinone derivate als inhibitoren von tau aggregation zur behandlung von alzheimer's und verbundenen neurodegenerativen erkrankungen
DE50112128D1 (de) Retardpartikeldispersion
DE602004010130D1 (de) Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege
PL1613720T3 (pl) Czyszczące kompozycje emulsji wielokrotnych
ATE432278T1 (de) Verbindungen zur behandlung von krankheiten
TW200716172A (en) Pharmaceutical compositions for treating lower motor neuron diseases
TNSN03065A1 (en) BIOPESTICIDE COMPOSITIONS
WO2007119029A3 (fr) Co-cristaux de calixarenes et de molecules biologiquement actives
BRPI0513051A (pt) combinação de inibidores de transcriptase reversa e de protease anti-hiv
ATE358992T1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
ATE469657T1 (de) Immunstimulatorische kombination zur vorbeugung und behandlung von hepatitis c
DE60312684D1 (de) Plazenta-wachstumsfaktor als target für die behandlung von osteoporose
ATE515188T1 (de) Verfahren zur bekämpfung von insekten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties